Core Viewpoint - Chao Yan Co., Ltd. has shown a mixed performance in terms of stock trading and financial results, with a slight increase in stock price but a decrease in revenue and net profit year-on-year [1][2]. Group 1: Stock Performance - On December 18, Chao Yan Co., Ltd. saw a stock price increase of 1.07%, with a trading volume of 23.52 million yuan [1]. - The financing buy-in amount for the day was 1.30 million yuan, while the financing repayment was 1.97 million yuan, resulting in a net financing buy of -0.66 million yuan [1]. - As of December 18, the total financing and securities lending balance was 77.93 million yuan, with the financing balance accounting for 6.11% of the circulating market value [1]. Group 2: Financial Performance - For the period from January to September 2025, Chao Yan Co., Ltd. reported a revenue of 25.4 million yuan, representing a year-on-year decrease of 2.90% [2]. - The net profit attributable to shareholders for the same period was 8.89 million yuan, down 3.66% compared to the previous year [2]. - Cumulative cash dividends since the A-share listing amounted to 43.69 million yuan [2]. Group 3: Shareholder Structure - As of September 30, 2025, the number of shareholders for Chao Yan Co., Ltd. was 17,000, a decrease of 23.90% from the previous period [2]. - The average circulating shares per person increased by 39.99% to 3,438 shares [2]. - The largest circulating shareholder is Huabao Zhongzheng Medical ETF, holding 1.52 million shares, which decreased by 388,200 shares from the previous period [3].
超研股份12月18日获融资买入130.33万元，融资余额7776.93万元